INCRAFT低剖面主动脉支架系统INSPIRATION研究五年结果
INSPIRATION研究是一项开放标签、前瞻性、非随机、单臂研究,在美国和日本32个中心纳入190例腹主动脉瘤患者,评估INCRAFT低剖面支架系统的5年疗效与安全性。结果显示30天主要不良事件发生率为3.2%,围手术期技术成功率为94.1%,1年无支架断裂率为97±1%,5年降至87±3%,5年无动脉瘤相关死亡率为99±1%。
要点
- 30天主要不良事件发生率为3.2%(6/190)。
- 围手术期技术成功率为94.1%(176/187)。
- 5年无支架断裂率为87±3%,无动脉瘤相关死亡率为99±1%。
核心结论
- INCRAFT装置在具有高比例挑战性解剖结构的人群中显示出良好的疗效和安全性,动脉瘤相关死亡率极低。
研究设计与样本
- 开放标签、前瞻性、非随机、单臂研究,在美国和日本32个中心纳入190例腹主动脉瘤患者,平均年龄73.8±7.6岁,90%男性,69%白人,30%亚洲人。
主要发现
- 30天主要不良事件发生率为3.2%(6/190)。
- 围手术期技术成功率为94.1%(176/187)。
- 成功动脉瘤治疗30天为100%,1年为87.9%。
- 2例因血栓栓塞并发症需开放转换,3例出现新发I型或III型内漏,7例发生移植物或肢体闭塞。
- 1年无移植物闭塞率为96±2%,5年为94±2%;1年无支架断裂率为97±1%,5年为87±3%;1年和5年无动脉瘤相关死亡率均为99±1%。
局限性
- 本研究为单臂非随机设计,未设立对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We present the 5-year results of a prospective regulatory study of the INCRAFT device, a low-profile endovascular stent graft system for repair of abdominal aortic aneurysms. METHODS: This was an open-label prospective nonrandomized single-arm study enrolling in centers in the United States and Japan. The primary effectiveness outcome was successful aneurysm treatment and the primary safety outcome was the incidence of major adverse events at 30 days after the procedure. Major long-term outcomes were mortality, reintervention, adverse limb outcomes, and suprarenal stent fracture. RESULTS: One hundred and ninety patients (mean age, 73.8 ± 7.6 years; 90% male; 69% white and 30% Asian) were enrolled from 32 centers throughout the United States and Japan. Minimal access vessel size was less than 7 mm on both sides in 43.9% of the study cohort. Thirty-day major adverse events occurred in 3.2% of patients (6/190). Periprocedural technical success was 94.1% (176/187). Successful aneurysm treatment was 100% at 30 days and 87.9% at 1 year. Two patients required open conversion for thromboembolic complications, 3 developed new type I or III endoleaks, and 7 experienced graft or limb occlusion. Freedom from graft occlusion was 96 ± 2% at 1 year and 94 ± 2% at 5 years. Freedom from stent fracture was 97 ± 1% at 1 year and 87 ± 3% at 5 years. Freedom from aneurysm-related mortality was 99 ± 1% at 1 and 5 years. CONCLUSIONS: This study demonstrates good efficacy and safety and a very low rate of aneurysm related deaths with the INCRAFT device in a population with a high proportion of challenging anatomy.
引用
- Liang NL, Ohki T, Ouriel K, et al. Five-year results of the INSPIRATION study for the INCRAFT low-profile endovascular aortic stent graft system. J Vasc Surg. 2020. PMID: 32707389. doi:10.1016/j.jvs.2020.06.128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。